You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
九洲藥業(603456.SH):擬出資5000萬元參投蘇州泰福懷謹創業投資合夥企業
格隆匯 08-16 16:32

格隆匯8月16日丨九洲藥業(603456.SH)公佈,公司擬與蘇州懷謹投資管理合夥企業(有限合夥)、杭州泰格股權投資合夥企業(有限合夥)、雲南沃森生物技術股份有限公司、成都康華生物製品股份有限公司、寧波喬欣股權投資合夥企業(有限合夥)、張少榮、淄博淳涵投資合夥企業(有限合夥)、寧波泰得創業投資合夥企業(有限合夥)、上海三友醫療器械股份有限公司、蘇州市創新產業發展引導基金(有限合夥)、蘇州工業園區生物產業發展有限公司、崑山興華投資諮詢中心(有限合夥)、長三角(嘉興)戰略新興產業投資合夥企業(有限合夥)、長三角協同優勢產業股權投資合夥企業(有限合夥)共同參與投資蘇州泰福懷謹創業投資合夥企業(有限合夥)。

合夥企業擬定規模約為人民幣20億元,公司將作為有限合夥人認繳出資額為人民幣5000萬元。截止公吿日,合夥企業已獲得認繳募集資金總額為人民幣17.97億元(不含公司擬認繳額5,000萬元)。

合夥企業主要投資於生物醫藥、生物技術、醫療健康等相關領域。此次投資合夥企業符合公司未來整體發展戰略,有利於拓寬公司在醫療大健康前沿領域的佈局,同時公司將藉助專業投資管理機構的投資經驗和專業能力,拓展公司投資渠道,獲取投資收益,發展優質項目儲備。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account